159 related articles for article (PubMed ID: 37951862)
1. Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience.
Zheng L; Zhang X; Nian Y; Zhou W; Li D; Wu Y
BMC Gastroenterol; 2023 Nov; 23(1):386. PubMed ID: 37951862
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital].
He N; Hao S; Feng G; Gao J; Kong FJ; Ren ZX; Xu MQ; Yang YQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1053-1058. PubMed ID: 34933422
[No Abstract] [Full Text] [Related]
3. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C screening in hospitals: find the missing patients.
Liu L; Xu H; Hu Y; Shang J; Jiang J; Yu L; Zhao C; Zhang D; Zhang X; Li J; Li W; Wu Y; Hu D; Wang X; Zhao Q; Zhang Q; Luo W; Chen J; Zhang D; Zhou W; Niu J
Virol J; 2019 Apr; 16(1):47. PubMed ID: 30992019
[TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
6. [In-hospital process for viral hepatitis C screening and management in China (Draft)].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2021 Apr; 29(4):319-325. PubMed ID: 33979957
[TBL] [Abstract][Full Text] [Related]
7. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
Fernández-García CE; Gallego-Galiana J; Solís-Muñoz PA; Del Pozo-Maroto E; Domínguez-Alcón L; Tobar-Izquierdo M; Sáez A; Rodríguez de Cía J; Magaña-Sánchez A; Real-Martínez Y; García-Buey L; González-Moreno L; Caldas-Álvarez M; Cardeñoso-Domingo LM; González-Gamarra A; Salvador-Calvo A; González-Rodríguez Á; García-Monzón C
Infect Dis Now; 2024 Mar; 54(2):104855. PubMed ID: 38309646
[TBL] [Abstract][Full Text] [Related]
8. Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada.
Selfridge M; Barnett T; Lundgren K; Guarasci K; Milne R; Drost A; Fraser C
Public Health Nurs; 2022 Sep; 39(5):1009-1016. PubMed ID: 35537120
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
[TBL] [Abstract][Full Text] [Related]
10. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study.
Yen HH; Su PY; Liu II; Zeng YH; Huang SP; Hsu YC; Hsu PK; Chen YY
BMC Gastroenterol; 2021 May; 21(1):209. PubMed ID: 33964873
[TBL] [Abstract][Full Text] [Related]
11. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
12. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea.
Lee JS; Choi HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
J Gastroenterol Hepatol; 2021 Sep; 36(9):2479-2485. PubMed ID: 33788314
[TBL] [Abstract][Full Text] [Related]
13. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study.
Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Sharafi H; Shafiei M; Zarei J; Mousavian G; Tavakoli F; Ghalekhani N; Shokoohi M; Khezri M; Mehmandoost S; Shojaei MR; Karamouzian M; Briceno A; Morris MD; Alavian SM; Haghdoost AA; Sharifi H; Page KA
Int J Drug Policy; 2022 Apr; 102():103580. PubMed ID: 35074607
[TBL] [Abstract][Full Text] [Related]
14. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of HCV Infection and Risk Factors in a Hospital- Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study.
Gheorghe L; Iacob S; Csiki IE; Huiban L; Cojocaru M; Cojocariu C; Nemteanu R; Girleanu I; Sirli R; Singeap AM; Pop C; Dumitrascu DL; Vadan R; Iacob R; Diculescu M; Trifan A; Sporea I; Gheorghe C
J Gastrointestin Liver Dis; 2020 Dec; 29(4):587-593. PubMed ID: 33331354
[TBL] [Abstract][Full Text] [Related]
17. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
Rosato V; Kondili LA; Nevola R; Perillo P; Mastrocinque D; Aghemo A; Claar E
Viruses; 2022 May; 14(5):. PubMed ID: 35632837
[No Abstract] [Full Text] [Related]
18. Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China, and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data.
Li Y; Zhao L; Geng N; Zhu W; Liu H; Bai H
Virol J; 2020 Mar; 17(1):36. PubMed ID: 32178702
[TBL] [Abstract][Full Text] [Related]
19. Elimination of hepatitis C in a hospital characterized by infectious diseases.
Han Y; Zheng M; Meng H; Han J; Chen J; Wang Y
Front Public Health; 2023; 11():1093578. PubMed ID: 37006527
[TBL] [Abstract][Full Text] [Related]
20. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Tai CM; Huang CK; Changchien TC; Lin PC; Wang DW; Chang TT; Chan HW; Chen TH; Tseng CH; Chen CC; Tsai CT; Sie YT; Yen YC; Yu ML
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
